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Department of Pharmacology, University of Nijmegen, Nijmegen, The Netherlands
1 The renal handling of iohexol was examined in the rat isolated perfused kidney (IPK)
- 1
over a
perfusate concentration range of 5 -2 0  /¿g ml
2 At a concentration of 5 ¿¿g m l ' \  a ratio of renal clearance over clearance by glomerular
ratio mcreas 1.02 + 0.06 at /ig ml 1(C1r/GF) o f 0.63 ± 0 .06  could be
indicating that a saturable mechanism is involved in the luminal disappearance of the drug.
3 Pretreatment of the kidneys with polylysine, probenecid or diatrizoate resulted in a significantly 
enhanced clearance o f  iohexol, probably due to inhibition of membrane binding. Renal clearance data 
were fitted to a kinetic model including filtration into the primary urine followed by saturable absorption 
at the luminal membrane. An absorption constant, KA, o f 7 .3+ 1 .3  /ig ml 1, and a maximum rate of 
absorption, FA.Max, ° f  1 .4+  0.1 /ig m in~1 were determined.
4 Iohexol accumulated in kidney tissue, reaching a concentration of 2 to 7.5 times the perfusate 
concentration. In freshly isolated proximal tubular cells and kidney cortex mitochondria, iohexol reduced 
the uncoupled respiratory rate at a concentration comparable to the highest tissue concentration found 
in the IPK.
5 In conclusion, iohexol is not only filtered by the kidney but also reabsorbed via a saturable 
mechanism, which results in tubular accumulation. Intracellularly sequestered iohexol may affect 
mitochondrial oxidative metabolism. Our results indicate that iohexol is not a true filtration marker.
Keywords: Perfused kidney; iohexol; contrast agent; glomerular filtration; membrane binding; saturable absorption; tubular
accumulation; mitochondrial respiration
Introduction
Iodinated contrast media are widely used for the imaging of high intracellular concentrations may directly affect tubular
organs and blood vessels. The currently used intravascular cell integrity and be the basis o f  the nephropathy induced,
contrast media are derivatives o f triiodinated benzoic acids, However, the mechanism of direct tubular cell injury remains
and most compounds are excreted primarily by the kidney. to be elucidated (Bakris, 1993). Among a variety o f suggested
While being cleared the contrast agent is concentrated by the mechanisms, some studies have shown that a reduction in renal
kidney and provides good visualization o f the entire renal oxidative metabolism can occur, which may be caused by a
system. All triiodinated contrast media arc hyperosmolar. diminished oxygen or a •ect interaction with
metabolically stable, and can be divided roughly into two mitochondrial respiration (Humes et al., 1987; Hey man et al.,
the ionic, high osmolar ( 1 ,2 0 0major groups;
2,000 mOsm T '), iind nonionic and relatively low osmolar 
agents (300-650  mOsm I"1) (Morris & Fischer, 1986; Bakris, 
1993; Sovak, 1994).
1988; Bakris, 1993).
The existence o f an endocytotic mechanism is in contra­
diction with other data indicating that iohexol may be useful as 
a marker for the determination o f glomerular filtration rate
A drawback in the use o f  radiocontrast media is the risk of (GFR). In these studies the contrast agent was supposed to'be 
acute renal failure. Factors involved in nephropathy are renal handled by the kidney in a fashion similar to inulin, implying 
haemodynamic alterations, direct tubular cell injury and tub- that neither secretion nor reabsorption occurred (Frennby et
ular obstruction (Bakris, 1993; Porter, 1994). Although ne­
phrotoxicity has been shown to be more severe with the use of
al., 1994; Lindblad & Berg, 1994).
In this study we examined the renal handling of iohexol in
high-osmolar contrast agents (Thomsen et al., 1988), in pa- the rat isolated perfused kidney (IPK). Previously, we showed 
tients with pre-existing renal failure the incidence o f contrast that the IPK is a useful model for studying the renal clearance 
nephropathy was not significantly different when comparing and accumulation o f drugs, and their effects on kidney fune-
high and low osmolar media (Barrett et al., 1992). Nonionic tion (Cox et al., 1991; Boom et a i ,  1994). The purpose of this
contrast media have even been shown to induce more mor- study was to investigate the presence and role o f a re absorptive
phological changes in proximal tubules of the kidney. For mechanism in the overall clearance of iohexol in the IPK, and
iohexol, vacuolization was observed in proximal convoluted 
tubular cells (Tervahartiala et al., 1991; Beaufils et a i ,  1995).
the effect o f intracellularly sequestered drug on mitochondrial 
oxidative metabolism. The results reveal that iohexol clearance
Heyman et al. (1988) suggested that the vacuoles are developed is determined by filtration and saturable absorption, resulting 
by invagination o f  membranes of lateral cellular interdigita- m
tions. However, it has also been speculated that the vacuoles 
might be secondary lysosomes, in which the contrast medium 
is sequestered, and formed after the drug enters tubular cells 
from the tubular lumen via endocytosis (Nordby et al., 1 
If the renal handling of contrast agents comprises endocytosis M ethods  
and, subsequently, accumulation within proximal tubular cells,
ar seques­
tration of iohexol appears to affect mitochondrial oxidative
-W« c">* , 1 . SMl. a >
1Author for correspondence at: Departm ent of Pharmacology 233, 
Faculty of Medical Sciences, University of Nijmegen, PO Box 9101, 
6500 HB Nijmegen, The Netherlands
Experimental procedure
The isolation and perfusion o f the rat kidney has been de­
scribed in detail previously (Cox et al., 1990). Pluronic F- 
was used as an oncotic agent in the albumin-free perfusion
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fluid. For the determination of glomerular filtration rate 
(GFR), cyanocobalamin was added to the perfusion fluid, 
GFR was monitored on line by a micro flow-through cuvette 
in which the cyanocobalamin concentration was measured 
colorimetrically (Brink & Siegers, 1979). The experimental 
period was 120 min and started after a 30 mill baseline period. 
During the baseline period the perfusate volume was 500 ml 
from which a sample of 5 ml was drawn. After the baseline
Analysis
Urine and perfusate samples were analyzed for electrolytes 
and glucose, as described in a previous paper from our de­
partment (Cox et al., 1990). The concentration of iohexol in 
perfusate and urine samples were determined by use of re- 
versed-phase high-performance liquid chromatography 
(h.p.l.c.), as described below. This h.p.l.c. method could not be
period, the experimental perfusion fluid was connected to the used for the determination o f  iohexol concentrations in kidney
kidney, with a total volume of 250 ml in which iohexol was 
already dissolved. Doses added to the perfused kidneys were 0
tissue, because iohexol could not be separated from all tissue 
components. Concentrations in the kidneys were determined
(time controls), 1.25, 1.88, 2.5 and 5.0 mg of iohexol, resulting by a chemical method according to Bäck et al. (1988). The
in initial perfusate concentrations of 5, 7.5, 10, and kidneys were homogenized in 5 ml distilled water with a 
20 fig ml“ 1. Compounds used to affect iohexol clearance were Polytron homogenizer on setting 10 for 2 times 60 s. A sample 
a contrast analogue, diatrizoate, an inhibitor of organic anion of 50 jul was used for further determination. Inulin con-
transport, probenecid, and an inhibitor of aminoglycoside 
brush-border membrane binding, polylysine. These agents
centration in kidney tissue and in perfusion samples were de­
termined according to Heyrovski (1956). Protein content in
were added to the IPK at the start of the baseline period, and each proximal tubular cell and kidney cortex mitochondrial
remained in the perfusion fluid during the experimental period. 
Urine samples were collected during control and experimental
preparation was determined by use of the Bio-Rad Protein 
Assay from Bio-Rad (Miinchen, Germany) with BSA as
periods over 10 min intervals. Perfusate samples (300 /¿I) were protein standard.
drawn at the midpoint of each urine collection interval. Two
additional perfusate samples were taken, one at the beginning H.p.l.c. assay
of the experimental period (i = 0), and one at the end of the 
experiment. At the end of the experiment the kidney was re­
moved from the system, blotted, weighed, and frozen until 
analysis. Urine and perfusate samples were stored at -  
until analysis.
20°C
Respiration m easurements
The effect of iohexol on cellular and mitochondrial respiration 
was determined in rat isolated kidney proximal tubular cells 
and kidney cortex mitochondria. Proximal tubular cells were 
isolated as described previously (Masereeuw et al., 1994) and 
suspended to 10-15  mg protein ml-1 in incubation buffer 
containing (mM): NaCl 117.5, KC1 4, M gS04 1.2, KH2P 0 4, 
0.95, N aH C 03 22.5, glucose 11.1 and CaCl2, 2.5. Rat kidney 
cortex mitochondria were isolated as described by Cain & 
Skilleter (1987), with some modifications. All steps were car­
ried out at 4°C. Briefly, kidneys were isolated after perfusion 
with an ice-cold solution containing 140 mM NaCl and 10 mM 
KC1. The capsula was removed, medulla was dissected and 
cortex was collected in a Potter-EIvehjem homogenizer with 
Teflon pestle (clearance 0.5 mm) in three times the tissue 
weight of homogenization buffer (300 mM mannitol, 10 mM 
HEPES, 1 mM EGTA, 1 mg ml“ 1 BSA at pH 7.4). Tissue was 
homogenized gently six times by hand, and suspension was 
centrifuged for 10 min at 500 g. Supernatant was collected and 
centrifuged for 7 min at 11,000 g. Pellet was washed with
homogenization buffer and centrifuged (7 min,
A 1084B Liquid Chromatograph of Hewlett Packard (Böblin­
gen, Germany) was used, equipped with an auto-injector (HP 
79841 A), terminal (HP 79850 B LC) and an u.v. absorbance 
detector (Spectroflow 773, Kratos analytical instruments, 
Ramsey, N.J., U.S.A.) at an operating wavelength of 254 nm. 
Chromatography was performed on a stainless steel column 
(125 x 4 mm) packed with LiChrospher 60 RP-Select B (Merck, 
Darmstadt, Germany), particle size 5 pim. The mobile phase 
consisted o f 0.01 M potassium dihydrogen phosphate buffer 
(pH 2.6) and flow rate was 0.3 ml min- '. Iodopyracet was used 
as internal standard (0.1 mg ml~ ‘). With a column temperature 
of 40°C, iohexol eluted as two peaks with retention times of 7.4 
and 8.6 min with a ratio o f  1:4. Within the same run, iodo­
pyracet eluted with a retention time of 10.4 min. Sample pre­
paration was performed with YM-10 ultrafiltration membranes 
(13 mm i.d.) with a molecular weight cut-off of 10,000 in the 
MPS-l micropartition system (Amicon, Grace BV, Capelle a/d 
Ijssel, The Netherlands) to separate iohexol and pluronic F- 
108. Onto the membrane, 2 0 -3 0  ¡.d urine or 50-150  ¡il per­
fusate sample was pipetted, together with 50 f.d o f internal 
standard. Total volume was adjusted to 300 /d with mobile 
phase buffer (pH 2.6). The filter units were centrifuged for 
20 min at 3,000 g and 180 /¿I of the filtrate was mixed with 
320 jUl mobile phase buffer. An aliquot of 20 /d of the resulting 
solution was injected onto the column. Concentrations in per­
fusate and urine were determined by comparing the peak area 
ratio of the second (and major) peak of iohexol and internal 
standard with a calibration curve of peak area ratio w>\ iohexol 
concentration spiked to blank perfusate and urine. Linear ca­
libration curves were obtained in all cases (r> 0 .9 8 )) . The in-
terday precision of the h.p.l.c. b y
measuring a spiked perfusate and urine sample with each run. 
The coefficient of variation was found to be 8.7% for the per­
fusate sample ( lO ^ g m !“ 1, n = l l )  and 10.7% for urine 
(100 /ig m l-1, n = 12).
11,000 g). Final pellet was diluted to a concentration o f  
5 mg m l“ 1 mitochondrial protein in respiration medium 
(210 mM mannitol, 10 mM KC1, 10 mM KH2P 0 4, 0.5 mM 
EGTA, 60 mM Tris-HCl, at pH 7.4).
Respiration measurements were done with a Clarke-type 
platinum electrode, with 1 mg of cellular or mitochondrial 
protein in 2.0 ml of medium. Basal cellular 0 2 consumption 
was measured at 37°C in incubation buffer supplemented with 
4 mM sodium lactate, 1 mM alanine, and 10 mM butyric acid 
(pH 7.4). Uncoupled cellular respiration was determined in the 
presence of 44 ¡iM dinitrophenol (DNP). Mitochondrial oxy­
gen consumption was measured at 30°C in respiration medium The renal excretion of iohexol appeared to be composed of 
in the absence of adenosine 5'-diphosphate (ADP) (state 2), in glomerular filtration and saturable absorption, which was as- 
the presence of ADP (state 3), after ADP consumption (state sumed to take place at the luminal side. Since plasma proteins 
4), and after the addition o f DNP, (final concentration 44 /¿m). were not present in perfusate and iohexol did not bind to any 
Succinate (10 mM) was used as the metabolic substrate, and o f the perfusate constituents, drug concentrations can be 
rotenone (1 ¡jm) was added to block electron transport prox- considered as unbound. The renal excretion rate of iohexol can 
imal to succinate entry into the respiratory chain. ADP- therefore be expressed as: 
stimulated respiration (state 3) was measured in the presence of
Renal excretion
0.3 mM ADP. Respiratory rates were calculated and expressed 
as nanogram atoms of oxygen per minute per milligram of
protein (ng atom O min 1 mg i prot.).
R r Q gf ■ Cp
Va.Mux • K a
K a  4 -  C p (1)
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Renal clearance is described by:
ClR =
C p
(2)
Table 1 Experimental conditions of the rat isolated 
perfused kidney (IPK) in the baseline period of all IPK 
experiments“
where QCP =  glomerular filtration rate (ml min“ 1); R r =  renal 
excretion rate (fig m in-1)» C/r =  renal clearance (ml min-1); 
Cp = drug concentration in perfusate (fig ml” 1); Ka.mh* 
= maximum rate of absorption (fig min ~ 1 ); i£A = Michaelis- 
Menten constant o f absorption (fig m l“ 1).
Mater ial s
Pluronic F-108 was from BASF (Arnhem, The Netherlands) 
and cyanocobalamin was obtained from Sigma (St.Louis, 
MO.). lohexol was purchased from Nycomed (Oslo, Norway), 
diatrizoate, probenecid and poly-l-lysine (Mw 1,000- 4,000) 
were from Sigma (St.Louis, MO.), iodopyracet was obtained 
from Dagra (Diemen, The Netherlands). Bovine serum albu­
min (BSA) and 4 - (2 - hydroxyethyl) -1 - piperazineethane- 
sulphonic acid (HEPES) were from Boehringer Mannheim 
(Mannheim, Germany). All other chemicals were of analytical 
grade and purchased from either Sigma (St.Louis, MO.) or 
Merck (Darmstadt, Germany).
Renal functional 
parameter Value
FEg|ul;os<; (%) 3.1 +  0.5
FENa (%) 1.8 +  0.5
FE K (%) 25 +  8
FEfa (%) 2 .4 ± 0 .7
FEM g(%) 4 4 +  12
G F R  (/¿I min ’) 414 +  47
Urinary flow (/¿l min ') 21 + 2
Urinary pH 5.5 +  0.2
RPP (mniHg) 88 ± 5
FRwuler (%)
Perfusate flow (ml min )
94.9 ±  0,4
12if 1
“D ata shown are means ± s .d „  « = 32. FE *  fractional exere-
tion, FR  =  fractional RPP -■ renal
Data analysis
All data are expressed as mean +  s.d. Statistical differences 
between means were determined with Student’s t test, in which 
the level of significance was set to / ><0.05. Renal excretion 
rate data were weighed reciprocally (1/Y2), and analyzed ac­
cording to equation 1 by the nonlinear least square regression 
program PCNonlin (Metzler & Weiner, 1986). The goodness 
of fit was evaluated through the deviation between observed 
and model predicted values as R~ = 1 — 2(Dev)72(Obs)", where 
E(Obs)“ is the observed sum of squared observations and 
E(Dev)2 is the sum of squared deviations.
Results
Kidney function
The mean values for the functional parameters of baseline 
period ( — 30 -  0 min) of all IPK experiments are presented in 
Table 1 (  ^=  32). After administration of iohexol, only small 
changes in renal function were observed. Compared to control 
IPK experiments, the renal perfusion pressure and fractional concentration (5 fig ml ') (Table 2). Figure 4 shows the ratio
filtration only. The line through the data points was obtained 
after analyzing renal excretion data over the period 30 to 
90 min, according to equation 1. The tubular titration curves 
for compounds that are actively reabsorbed, run below the 
glomerular filtration line and parallel it as this mechanism 
becomes saturated. Because the currently observed titration 
curve for iohexol diverges from the theoretical titration curve 
for active reabsorption, another approach had to be used to 
describe renal excretion data (equation 1). It is suggested that 
the drug binds to the luminal membrane of the kidney tubules 
and, subsequently, is internalized within the tubular cells. Sa­
turation of this absorption mechanism appeared from the ti­
tration curve: at higher perfusate concentration the renal 
excretion rate line coincided with the glomerular filtration line. 
The insert of Figure 3 shows that this situation continues at 
perfusate concentrations up to 225 fig ml"'1. Parameters ob­
tained after fitting equation 1 to the data were a KA>Mnx of
1.4±0.1 jug min.1 and a KA of 7.3 ± 1 .3  /¿g ml 1
cient of determination (R2) was 0.968.
To investigate further iohexol binding, studies were per­
formed in which the perfused kidneys were pretreated with 
diatrizoate, probenecid, or polylysine. All three agents were 
able to enhance iohexol clearance at the
excretions o f electrolytes and glucose were not altered. GFR, 
and urinary flow and pH were slightly changed in comparison 
to control experiments, and plotted against time after nor­
malizing data to their control values (Figure la). At a perfu­
sate concentration of 5 fig ml.1 iohexol, pretreatment with
diatrizoate, probenecid or polylysine abolished the functional 
alterations (Figure lb).
of renal over clearance by glomerular iiltration
during the experimental period (0 -120  min) for all treatments. 
The ratio increased during the first 30 min of the experiment
stable for the rest of the time, 
ratio showed a dose-de-
rerma maximum, i 
The plateau value o f the C7r/CI
and
It is obvious that all
1 at a perfusate concentration oí
Renal excretion o f  iohexol
Iohexol was slowly eliminated from perfusion fluid. Figure 2 
shows the time course of the mean perfusate concentration and 
corresponding excretion rate data of the four iohexol doses 
studied, as a function of time. All doses gave linear con- 
centration-time curves. The urinary excretion rate increased 
rapidly after addition of iohexol, followed by a gradual de­
crease. Renal handling data are presented in Table 2. At a low 
perfusate concentration (5 /j,g ml ‘) the renal clearance was 
significantly lower than the clearance by glomerular filtration 
(C/r/G F <1), indicating reabsorption o f iohexol. At higher 
iohexol concentrations the ratio C/r/G F increased until I , in­
dicating that a saturable mechanism is involved in the luminal 
disappearance of the drug.
A plot o f the renal excretion rate against perfusate con­
centration, a so called tubular titration curve, is presented in
20 fig ml
iohexol clearance over the whole experimental period.
Renal accumulation o f  iohexol
The concentration of iohexol in the 
the amount of drug per weight of tissue, and is presented in 
Table 2. The concentration in kidney tissue divided by the 
concentration in perfusate at the end of the experiment, re­
ratio
ind at
in an
accumulation in 
r a t i o  1), and it was observed that at a low 
centration the accumulation ratio tended to 
high perfusate concentration it tended to be low, 
that a saturable mechanism is involved in drug tissue uptake. 
As a control, in three separate perfusion experiments the 
concentra tion of the filtration marker inulin was determined in 
kidney tissue and perfusion fluid, and a kidney/perfusate ratio 
of 0.123 +  0.007 was found. This indicates that accumulation
Figure 3. The dotted line represents clearance by glomerular of iohexol is a result of specific tubular cell binding and uptake,
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Figure 1 Glomerular filtration rate (GFR), urinary How and urinary pH, as a function of time are shown. Renal functional values 
are normalized for the mean value of the baseline period ( —30 to Omin). lohexol was administered at time / = 0min. Asterisks 
indicate significantly different from control ( P < 0.05), tested over the 30 to 120min experimental period, (a) The effects on kidney 
function of 4 different perfusate concentrations of iohexol and the results from control IPK (isolated perfused kidney) experiments 
are presented (n ** 4). Concentrations used were: non (control, +); iohexol 5 jug m l“ 1 ( • ) ;  7.5jugml“ ' (A); 1 0 / ig m P 1 (
1 (▼). (b) Kidney function in control IPK experiments ( + , n = 4) and at a perfusate concentration of 5 /ig m l~ l
1 polylysine (□ , « = 5), 200/ugml“ 1 diatrizoate (O. n — 3), or 86jtigml.1 probenecid (A . «= 4).
i».
20 ¡.ig ml 
together with 16ugml
) and
and that the contribution of concentration in extracellular fluid 
and tubular lumen to total tissue accumulation is negligible. 
Pretreatment with probenecid, diatrizoate and polylysine re­
sulted in a diminished tissue accumulation of iohexol, although 
kidney/perfusate ratios were not significantly altered.
D isc u ss io n
Respiration m easurem ents
Effect of iohexol on cellular and mitochondrial oxygen con­
sumption is illustrated in Figure 5. A concentration of 
80 jug m l"1 iohexol was used, which is comparable to the 
maximum concentration found in kidney tissue (Table 2). In merular filtration and saturable absorption, is able to describe
Clearance data of iohexol in the IPK showed that an absorp­
tive mechanism is involved in its renal handling, which is as-
to be initiated by binding to the brush-border 
membrane. It has been speculated previously that contrast 
agent molecules might enter tubular cells from the lumen, 
because high iodine concentrations were found at the brush- 
border region shortly after administration (Nordby e t  a l ,  
1990). However, the presence of such an absorptive mechanism 
was never demonstrated. Our kinetic model, comprising glo-
proximal tubular cells, basal respiration was not affected but the renal clearance data adequately. At perfusate concentra- 
DNP-stimulated respiration was significantly inhibited by io- tions above 20 ¿ig m l"1 saturation of absorption occurs. It is 
hexol. In our mitochondrial preparation DNP-stimulated re- most likely that because of the high doses used in human
spiration was also significantly reduced, indicating a reduction 
in oxidative metabolism. Iohexol did not alter basal and ADP  
stimulated mitochondrial oxygen consumption. A respiratory
studies, an absorptive mechanism was never observed, and 
iohexol was supposed to be suitable as a filtration marker. 
Most studies in human subjects were performed with doses
control ratio (ratio of state 3 respiration over state 4 respira- between 3 and 7 g, resulting in initial plasma concentrations of
tion) of 3.5 ±0.1 was determined for the control situation, 
indicating that our mitochondrial preparation is of good 
quality and tightly coupled. A ratio of 3.4 ±0 .3  was calculated 
in the presence of iohexol.
approximately 1000 times higher than used in our IPK ex­
periments (Frennby e t  al., 1994; Lindblad & Berg, 1994). Ac­
cording to our results, at these concentrations renal clearance 
will indeed be determined only by glomerular filtration.
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Figure 2 lohexol perfusate concentration (a) and urinary excretion
as a function of time. Doses added to the perfused kidneysn  »
were l.25 (# ) ;  1.88 (A); 2.5 ( ■ )  and 5 .0 mg (▼). All data points are 
means of 4 experiments. For the sake of clarity standard deviations 
were omitted from this figure, but varied between 5 and 18% for 
perfusate concentration, and between 10 and 35% lor renal excretion 
rate values.
The renal clearance of iohexol was enhanced after pretreat­
ment with diatrizoate, polylysine, or probenecid, probably due 
to inhibition of membrane binding. Polylysine has been shown 
to inhibit aminoglycoside binding to brush-border membranes 
of rat kidney cortex. Moreover, in vivo nephrotoxicity could be 
prevented when coadministered with gentamicin (Williams et 
al., 1986). It is possible that iohexol interacts with brush-border 
membrane components in a fashion similar to aminoglycosides. 
Subsequently, drug molecules are internalized in the tubular
cells an endocytotic anism, and
within the lysosomal compartment. This sequestration may 
account for the observed vacuolization for iohexol in the 
proximal tubular cells (Tervahartiala et al., 1991; Beauiils et 
al., 1995). Although Hey man et al. (1988) previously suggested 
that vacuoles are not a result of endocytosis, but formed after 
membrane injury induced by contrast agents from the para- 
cellular zones. The clearance profile and tissue accumulation of 
iohexol in our IPK preparations, however, indicate that a re- 
absorptive process for the drug exists. Although we cannot 
differentiate between basolateral or luminal binding in the IPK, 
it seems likely that the luminal membrane is involved. Addi­
tional binding studies with isolated membrane vesicles of both 
membranes are needed to discriminate between basolateral and 
luminal binding. Supporting evidence for the luminal binding is 
provided by various studies on disruption of the brush-border 
membrane by contrast media. Tubular cells seem to be even 
more sensitive to membrane injury than to lysosomal dis­
turbance after contrast medium administration (Thomsen et al 
1988; Bakris, 1993). This is comparable to the membrane da­
mage caused by aminoglycoside antibiotics, and supports our 
hypothesis that iohexol is handled by the kidney in a way 
comparable to aminoglycoside antibiotics. It is assumed that 
the cationic aminoglycosides bind to anionic phospholipids 
within the brush-border membranes (Kaloyanides, 
Whether membrane binding of nonionic iohexol molecules is 
based on a similar charge interaction between the amino groups 
of this contrast agent and membrane phospholipids, demands 
further research.
The inhibitor of organic anion transport, probenecid, also 
affected the renal clearance of iohexol. The effect of probenecid 
was investigated, because the tubular titration curve for io­
hexol in the IPK diverged from the theoretical curve, and a 
secretory component may be involved in the renal clearance of
iohexol. In addition, 
that the reduced renal accumulation of the contrast an
was a result of inhibition of organic anion transport (Mudge et 
a l 1971). Contrary to these findings, probenecid 
clearance of iohexol in our IPK prepan 
of inhibition of tissue:r, may
an an interaction with the binding site for iohexol. 
Previous studies have shown that probenecid 
uptake (Kippen et a l 1979) and organic cation 
(Choi & Kim, 1992) also, by a reduction in oxidative .sta-
Table 2 Renal handling data of iohexol in the rat isolated perfused kidney“
Dose
(mg)
Perfusate eanc. 
(/ig ml ')
Renal excretion 
rate (/ig min'"1) Cl/ilGF
Amount in 
kidney (/ig g ‘ )
Kidney/perfusate
ratio
1.25 5.6 ± 0 .6 1.2 ±0.3 0.63 ±0.06 39 ±  25 7.5 ±5.1
1.88 7.4 ± 0 .4 2.0 ± 0 .2 0.79 ±0.05 35 ±21 3 .1+  1.7
2.5 10 ±  1.6 2.7 ± 0 .5 0.85 ±0.06 3 4 ± 7 2 .2±0 .3J
5.0
1
16 + 0.5 5.3 ±0.1«"•Aw* 1.02 ±0.06 64 ±  16 2.7 ±0.9
1.25 5.3+ 0.4 1.8+0.2* 0.93 +  0.03*n  nit- ^ 25 ±  5 5.2 +1.5
1.25° 5 .9+  0.8 1.5 ± 0 .2 0.77 +  0.04* 31 ± 7 5.6 +1.9
1.25 4.9 ±0 .5 1.2 ± 0 .2 0.81+0.03* 15±8 3,4 4-2.0
“ Data shown are m eans± s.d . (« =  3 - 5 )  over the period of 30 to 90 min, except for the amount in kidney which was determined at the 
end of the experiment. C 7r/G F : ratio o f renal clearance over clearance by glomerular filtration. bIn the presence of 200 /¿g ml 1 
diatrizoate, “86 jug m l 1 probenecid, d 16 /¿g ml 1 polylysine. *P< 0 .05  in comparison with same dose without treatment. %P <0,05 in 
comparison with same ratio after a dose of 1.25 mg.
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Figure 3 Tubular titration curve of iohexol. Renal excretion rate 
and rate of filtration as a function of perfusate concentration. Data 
obtained over the period 30-90m in  are means of 4 experiments. The 
solid line represents the fit according to equation 1, the dashed line 
corresponds to the clearance by glomerular filtration only. All data 
were corrected for the fall in glomerular filtration rate (GFR) during 
the experiment. Insert: renal excretion rate as a function of perfusate 
concentration with 3 additional doses, resulting in initial perfusate 
concentrations 50, 100 and 250/zgml-1 (n = l) . Solid and dashed 
lines are positioned on top of each other.
The effect of diatrizoate was investigated because this con­
trast analogue is structurally related to iohexol, but negatively 
charged. Renal stop-flow experiments in the dog showed that 
the renal clearance of diatrizoate over inulin clearance was 0.9 
(Mudge et a l ,  1971), indicating that a similar reabsorptive 
mechanism may be involved in diatrizoate clearance. The en­
hanced iohexol clearance after pretreatment with diatrizoate is 
probably a result of a decreased binding. Whether there is 
competition for the same binding site, remains to be eluci­
dated.
At concentrations much lower than those used clinically, io­
hexol accumulated in kidney tissue reaching tissue concentra­
tions of 2 to 7.5 times the medium concentration. We 
investigated whether internalized iohexol affected oxidative 
metabolism, as was found for high osmolar contrast agents 
(Humes et a l ,  1987; Heyman et a l ,  1988). Although a direct 
effect of iohexol on basal and ADP stimulated respiration was 
not observed, the uncoupled respiratory rate was significantly 
reduced in both cell and mitochondrial preparations. The un­
coupling agent dinitrophenol discharges the proton electro­
chemical gradient across the mitochondrial inner membrane, 
thereby stimulating oxygen consumption without ATP synth­
esis. Reduction in uncoupled respiration is an indication of loss 
of respiratory control and a reduction in mitochondrial oxida­
tive metabolism (Cain & Skilleter, 1987), indicating that this low 
osmolar contrast agent may induce direct tubular cell injury. 
Similar results were obtained with the high osmolar agent dia­
trizoate, and it was suggested that mitochondrial Na-K-ATPase 
was affected (Humes et a l ,  1987; Porter, 1994). Heyman et al. 
(1988, 1991) observed mitochondrial swelling and vacuolization 
after iothalamate administration, mainly in the medullary thick 
ascending limb. However, they concluded that renal injury 
through contrast media was indirect and induced by a limited 
oxygen supply in that part of the nephron. Humes et a l  (1987)
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Figure 4 Renal clearance over glomerular filtration clearance (GFR) 
of iohexol as a  function of time, (a) Four different perfusate
1 7.5/igml“' 1
5 ug ml
concentrations of iohexol were studied: 5 /igm l“ (
(A), 10/igml“ 1 (■ )  and 2 0 / ig m P 1 (▼). (b) A concentration of
1 iohexol was used, after preincubation with diatrizoate (O, 
200 ¿¿g m l" 1), probenecid (A , 86/igm l“ 1)
-1). Data are means of 3 to 51 6 /ig m l"
deviations varied between 15 and 29%.
or polylysine (□ , 
experiments. Standard
With regard to our results, the use of iohexol as a filtration
showed that direct tubular cell injury may be additive to hypoxic marker may have clinical implications. In patients with im-
cell injury in radiocontrast-induced renal dysfunction. Although 
our perfused kidney preparation exhibited signs o f medullary 
thick ascending limb d efects after 150 min of perfusion, and also 
hypoxia in proximal tubules may occur (Cox et al., 1990), we did 
not expect this to have a major influence on our results, because 
in most experiments data over the period o f 3 0 -9 0  min were 
used. Furthermore, hypoxia limits all active transport processes
paired renal function, especially, the exposure time to contrast 
media is lengthened as a result o f a prolonged half-life, and 
drug accumulation may be more extensive. Previous studies 
have shown that renal insufficiency is an important risk factor 
in the development of contrast-associated nephropathy (Bar­
rett et a l ,  1992; Porter, 1994).
In summary, renal handling o f iohexol involves filtration
by reduction of cellular energy, and therefore, reabsorption o f and saturable absorption, resulting in tubular accumulation.
iohexol may have even been underestimated as compared to the 
in vivo situation.
The process of absorption is assumed to be initiated by binding 
of iohexol to the brush-border membrane, and can be inhibited
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Figure 5 Respiratory rate of rat freshly isolated kidney proximal tubular cells (a) and mitochondria (b), in control situation (open 
columns) and in the presence of 80/igml iohexol (hatched columns). State 2 respiration was measured before the addition of 
ADP, state 3 is the ADP-stimulated respiration, state 4 is the respiration measured after ADP consumption, and DNP is the 
dinitrophenol-stimulated respiration. D ata  are means +  s.d. (vertical lines) of 4 - 7  different preparations, asterisks indicate 
significantly different from control (P<0.05).
by polylysine, diatrizoate and probenecid. Intracellularly ac­
cumulated contrast medium affects mitochondrial oxidative 
metabolism. As a consequence, iohexol is not a true marker o f
GFR.
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